Re-evaluating the timing of sequential cranial ultrasound screening in very preterm infants for predicting neurodevelopmental outcomes.

Pediatr Radiol

Department of Diagnostic Radiology, Division of Pediatric Radiology, Dalhousie University, IWK Health, 5850/5980 University Avenue, PO Box 9700, Halifax, NS, B3K 6R8, Canada.

Published: December 2024

AI Article Synopsis

  • - The objective of the study is to determine whether a model using fewer cranial ultrasounds can accurately predict neurodevelopmental impairment in very preterm infants, as current practices involve four screening points.
  • - The research analyzed data from 656 very preterm infants born between 2004 and 2018, finding that 30% of them developed neurodevelopmental impairment by 36 months of age, while comparing different prediction models based on gestational age, sex, and ultrasound timing.
  • - Results indicated that the model using the 6-week ultrasound provided the best predictive ability for neurodevelopmental impairment, though all models showed similar effectiveness according to their statistical performance measures.

Article Abstract

Objective: Accurate and early prediction of neurodevelopmental impairment is a crucial endeavor in caring for very preterm infants (<31 weeks' gestation). Sequential cranial ultrasound is the standard of care for the evaluation of preterm brain injury. However, there is no consensus on the timing and frequency of ultrasound screening. At Izaak Walton Killam (IWK) Health Centre, Halifax, Canada, four-time points for routine ultrasound of very preterm infants are performed at weeks 1, 2, 6, and term age. The hypothesis behind this work is that a three-time-point model will be appropriate for neurodevelopmental impairment prognostication.

Materials And Methods: In this retrospective cohort, all very preterm infants (22-30 weeks) born between January 2004 and December 2018 with a neurodevelopmental assessment at 36 months corrected age were included. Three prediction models of neurodevelopmental impairment were compared: 1. A reference model including the gestational age, infant sex, and 2-week and 6-week ultrasound 2. A model including the gestational age, infant sex, and 6-week ultrasound 3. A model including the gestational age, infant sex, and 2-week ultrasound RESULTS: Of 786 eligible preterm infants born during the study period, 656/786 survivors were included in the analysis (mean gestational age 27 weeks, mean birth weight 1,133 g, and 55% male infants). At 36 months of corrected age, 30% developed neurodevelopmental impairment. All three models provided comparable discrimination areas under the curve (AUC) of neurodevelopmental impairment at 36 months of corrected age. Both the 6-week and the reference model had similar AUC of 0.68 (95% CI 0.63-0.72) and were not noticeably different from the 2-week model (AUC 0.66 (95% CI 0.61-0.70)). The 6-week model provided the best prediction with the lowest Akaike information criterion (AIC) of 766 for the 6-week-only model, AIC 769 for combined weeks 2 and 6 (reference model), and AIC 784 for the 2-week-only model.

Conclusion: In this cohort of very preterm infants, a model including 6-week ultrasound only was comparable to a reference model combining 2-week and 6-week ultrasound and showed nearly identical predictive performance of neurodevelopmental impairment at 36 months corrected age across a broad set of metrics; thus, it is redundant to do both the 2-week and 6-week ultrasound.

Clinical Relevance Statement: Late ultrasound at 6 weeks of age provided comparable diagnostic and prognostic information to a reference model combining 2-week and 6-week ultrasound and, if anything, was slightly superior to the 2-week ultrasound model, across a broad set of metrics. The 2-week ultrasound can be eliminated with no impact on the prediction of neurodevelopmental impairment at 36 months, promoting prudent resource allocation and stewardship in healthcare.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00247-024-06105-1DOI Listing

Publication Analysis

Top Keywords

preterm infants
8
re-evaluating timing
4
timing sequential
4
sequential cranial
4
cranial ultrasound
4
ultrasound screening
4
screening preterm
4
infants predicting
4
predicting neurodevelopmental
4
neurodevelopmental outcomes
4

Similar Publications

Introduction Respiratory distress syndrome (RDS) is a leading cause of morbidity and mortality among preterm infants, necessitating effective treatment strategies. This study compared the efficacy of Beractant (SURVANTA®) to Poractant alfa (CUROSURF®) in treating RDS in preterm infants admitted to Tawam Hospital in the UAE. Methodology This retrospective study included preterm infants from 23+0 to 36+6 weeks of gestation with a diagnosis of RDS and treatment by Beractant or Poractant alfa within 48 hours of life between January 2020 and March 2023.

View Article and Find Full Text PDF

Background: Intravenous lipid emulsions are an essential component of nutritional support for very preterm infants. Many neonatal intensive care units have transitioned from traditional soybean oil-only to fish oil-containing multicomponent lipid emulsions, but the neurodevelopmental implications have not been well-explored. The primary aim of this study was to assess extrauterine third trimester brain growth in very preterm infants supported with soybean oil-only compared to fish-oil containing multicomponent lipid emulsions; white matter development and neurobehavioral regulation at term were also investigated.

View Article and Find Full Text PDF

Background: Premature infants are at high risk for neonatal respiratory distress syndrome (RDS) and secondary infections. This study aims to investigate the association between immunoinflammatory markers-the systemic immune inflammation index (SII), systemic inflammation response index (SIRI), and neutrophil-to-albumin ratio (NAR)-and the risk of developing RDS in premature infants.

Methods: A total of 2164 premature infants were enrolled in this retrospective study.

View Article and Find Full Text PDF

Antenatal corticosteroids (ACS) are widely used to reduce respiratory distress syndrome (RDS) in preterm neonates, enhancing neonatal outcomes. However, the potential effects of ACS on other aspects of neonatal health, such as cortisol levels and glucose regulation, remain a concern. This study examines whether ACS administration impacts cortisol and glucose homeostasis in preterm infants by analyzing data from 14 selected studies.

View Article and Find Full Text PDF

Preterm birth, defined as delivery before 37 weeks of gestation, is a significant contributor to neonatal morbidity and mortality worldwide. Understanding the prevalence of preterm birth is critical to improving neonatal care, informing public health strategies, and supporting health care planning. The objective of this study was to explore the problem of preterm birth in Saudi Arabia by estimating the prevalence of preterm birth over a defined period of time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!